Google Alert - pharmaceutical news

News 9 new results for pharmaceutical news

Watson sues FDA on generic diabetes drug ruling Reuters India Watson planned to launch its generic version of Takeda Pharmaceutical Co Ltd's Actos on August 17 after a 2010 settlement with the Japanese drugmaker. Takeda also granted licenses to Mylan Inc and India's Ranbaxy Laboratories at that time to start ... See all stories on this topic »

Catalyst Pharmaceutical Partners Announces Second Quarter 2012 Financial ... NASDAQ 15, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the second quarter and six months ended June 30, 2012. For the three months ended June 30, 2012, the Company reported a ... See all stories on this topic »

Medicis Pharmaceutical Turns More Into Less DailyFinance Margins matter. The more Medicis Pharmaceutical (NYS: MRX) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders ... See all stories on this topic »

'I feel like a virgin': Indian pharmaceutical company sparks controversy with ... Daily Mail The launch of a new 'vaginal tightening and rejuvenating cream' by an Indian pharmaceutical company has sparked fury among the fairer sex. Not only have women voiced the opinion on Twitter that 18 Again was created by Ultratech purely to cash in on ... See all stories on this topic » Daily Mail

Medicis' skin drug gets generic threat from Actavis Mid Atlantic Reuters India (Reuters) - Medicis Pharmaceutical Corp said generic drugmaker Actavis Mid Atlantic filed a marketing application for a generic version of one of Medicis' skin drugs. The drug Zyclara is used to treat patients with actinic keratosis, a small, red ... See all stories on this topic »

Arena jumps 12% amid takeover speculation MarketWatch BOSTON (MarketWatch) -- Shares of Arena Pharmaceuticals (US:arna) jumped 12% to $8.12 on Tuesday amid speculation that a major pharmaceutical company could be mulling a buyout of the biotech group. The company recently received U.S. approval ... See all stories on this topic »

Med Tech's Arrest Shows Flaws in System Pharmaceutical Processing News, Views, & Technology for the Industry. Subscribe · Multimedia; Community; Products · News · Agencies and Organizations · Business News · Regulatory News · Pharmaceutical Companies · Outsourcing · Events · Equipment Vendors. Search PharmPro ... See all stories on this topic »

Cadence Pharmaceuticals' Management Presents at the 2012 Wedbush ... Seeking Alpha Introducing today Cadence Pharmaceuticals who launched their drug OFIRMEV about a year and a half ago and on the dollar basis, it's actually one of the more successful hospital-based launches in recent memory. Here today presenting is Scott Byrd. See all stories on this topic »

Skystar Bio-Pharmaceutical Reports Second Quarter 2012 Results Equities.com XI'AN, CHINA -- (Marketwire) -- 08/14/12 -- Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today ... See all stories on this topic »

---

This once a day Google Alert is brought to you by Google.

Delete this alert.
Create another alert.
Manage your alerts.